I. Introduction
Maternal mortality still remains very high in developing countries including India. Maternal Mortality Ratio (MMR) in India is 200 per 1 lakh live births. Medical conditions like eclampsia, ante-partum hemorrhage, post-partum hemorrhage all have increased MMR [1] . So the lifetime risk of maternal death is 1 in 170 livebirths. In India on an average one maternal death occurs every 10 minutes (UN report). Hypertension in pregnancy (16%) is one of the top five causes of maternal mortality. Hypertensive disorders of pregnancy represent a group of conditions associated with high blood pressure during pregnancy proteinuria and in some cases convulsions. The most serious consequences for the mother and baby are result of pre-eclampsia and eclampsia [2, 3, 4] .
Pre-eclampsia produces potentially lethal complications including placental abruption, disseminated intravascular coagulation, intracranial haemorrhage, hepatic failure, acute renal failure and cardiovascular collapse. Preeclampsia is still regarded as a disease of theories and its etiology has remained poorly understood. However, endothelial dysfunction has been considered to play a central role in the pathophysiology of preeclampsia [5] . The analysis of a combination of biochemical markers particularly markers related to vascular dysfunction such as increased uric acid, LDH, AST concentration may enrich the ability to predict and prevent PE in near future [6, 7] . Therefore the present study was designed to assess the association of different biochemical parameters like uric acid, LDH, AST, ALT, prothrombin time and APTT with maternal outcomes in PIH cases.
II. Materials And Methods
Study setting, study type: This prospective study was carried out in Obstetrics and Gynecology department of Shree Krishna Hospital attached to Pramukhswami Medical College, Karamsad, Gujarat, India. Study participants & study period: All pregnant woman admitted between January 2006-March 2008 in the hospital were examined. Blood pressure was measured by mercury sphygmomanometer in reclining position in right brachial artery. Three readings were taken at 10 minutes interval. Participants having average systolic blood pressure ≥ 140 mm hg and/or diastolic blood pressure ≥ 90 mm Hg were included in the study. Exclusion criteria: Patients with history of hyperuricemia, diabetes, renal diseases, cardiovascular illness, and symptomatic infectious diseases were excluded. Sample size and sampling: Purposively out of 2237 of total pregnant women admitted in the respected hospital in the defined study period, a total of 328 Participants having average systolic blood pressure ≥ 140 mm hg and/or diastolic blood pressure ≥ 90 mm Hg or chronic hypertension were included in the present study. Definitions 8 : Gestational hypertension is hypertension presenting after 20 weeks without significant proteinuria. Pre-eclampsia is hypertension presenting after 20 weeks with significant proteinuria. Severe pre-eclampsia is pre-eclampsia with severe hypertension and/or with symptoms, and/or biochemical and/or haematological impairment. Eclampsia is a convulsive condition associated with pre-eclampsia. Chronic hypertension is hypertension that is present at the booking visit or before 20 weeks or if the woman is already taking antihypertensive medication when referred to maternity services. It can be primary or secondary in etiology. HELLP syndrome is haemolysis, elevated liver enzymes and low platelet count. Data collection: After enrollment participants were grouped into mild PIH, severe PIH, eclampsia and chronic hypertension. Informed consent was taken from all the participants. The history of all participants was taken. Blood samples of participants were taken from right or left cubital vein and collected in plain and citrate tubes. Prothrombin (PT) and activated partial thromboplastin test (APTT) was performed by turbidometry method [9, 10] . Aspartate transaminase (AST) and Alanine transaminase (ALT) was measured by Ultra-violet kinetic method [11] . Uric acid was measured by modified Trinder"s test [12] and lactate dehydrogenase (LDH) was measured by UV kinetic IFCC [13] method. Participants were observed throughout pregnancy and maternal outcome was observed. This study was approved by the institutional ethical committee. Study variables: Predictor variables were ALT, AST, PT, APTT, LDH and Uric acid. Outcome variables were maternal complications or maternal death. Statistical Analysis: The data were cleaned, validated and analyzed with the help of Epi info 7. We used unpaired"t" test for comparing the mean level of uric acid, LDH, AST, ALT, PT, APTT with maternal outcome. p value < 0.05 was considered statistically significant.
III.
Results & Discussion Table 1 : Socio-demographic characteristics of the participants (n = 328)
Incidence of PIH in this study was 14.6%. Total number of deliveries in this study was 2237 out of which 328 were PIH cases. There were 117 (5.2%) cases with mild PIH, 136(6.0%) with severe PIH, 67(2.9%) with eclampsia and 8(0.35%) with chronic hypertension. Maternal deaths occurred in 9 PIH cases. MMR in this study was 4.5/1000 livebirths. Among them one had mild PIH -mortality 2/115 (1.74%), 4 had severe PIHmortality 4/132 (3.0 %) and 3 had eclampsia -mortality 3/ 64 (4.68 %). (Table 2) 
Chart A: Causes of maternal death in present study (n=9)
Isolated Thrombocytopenia (15.5%) was the most common maternal complication followed by pulmonary edema (8.8%) seen in present study. (Table 3) Table no 4 it"s obvious that there is a statistically significant relation between elevated serum ALT, AST, APTT, uric acid, LDH and maternal deaths. Prothrombin Time was not found to be significant in relation to maternal death All the 9 maternal deaths were admitted during emergency, 8(88.8%) came from rural areas; they belonged to low socioeconomic class and had not taken antenatal care. 7(77.7%) were illiterate, one had taken primary education and one was a graduate. 7 of the maternal deaths were primigravidas, 7 (77.7%) were from the 20-25yrs age group and 5(55.5%) cases were referred from outside hospital, this may be due to the fact that our institute is a well equipped and established tertiary care center located in a rural area, receiving a large number of high risk patients from surrounding locations.
Out of the 9 deaths 3 patients died in antepartum period, 3 in intrapartum period and 3 postpartum period. Out of these, 6 patients died undelivered, 2 delivered by vaginal route and one underwent LSCS.
There are several potential origins for raised uric acid concentration in preeclampsia, usually it"s secondary to altered renal function, increased tissue breakdown, increased oxidative stress and increased activity of xanthine oxidase [14] . In normal pregnancy due to plasma volume expansion Serum uric acid levels are between 2-5mg/dl. Greater then 5.5mg/dl is consistent with preeclampsia and values exceeding 6.0mg/dl suggest more serious disease [15] . Patient with both hyperuricemia and hypertension in the second half of pregnancy is more likely to have preeclampsia even in the absence of proteinuria. Uric acid with > 6mg/dl showed 21.5 fold risk of maternal mortality than in women with < 6mg/dl uric acid levels. Hyperuricemia patients with severe preeclampsia is a strong risk factor for several perinatal complications and increase the risk for intra uterine death by 30.4 times, cesarean section by 6 folds, maternal mortality by 21.5 times, IUGR by 6 folds and eclampsia by 14.3 fold in those with a uric acid level >6mg/dl as compared to a level <6mg/dl [16] .
Elevated uric acid levels had nearly seven fold increased risk of premature delivery than preeclamptic women whose uric acid levels were normal. One unit increase in uric acid the odds of preterm births increased 2-3 times [17] These finding are in agreement to our findings showing 100% maternal deaths, 77.6 % with eclampsia, and 26.8% with preterm delivery in hypertensive mothers with uric acid levels >6.0mg/dl (Table 5 ). Several studies have demonstrated a correlation between elevated maternal serum uric acid levels and adverse maternal outcome, to be useful test to predict maternal complications in the management of women with preeclampsia [18, 19, 20] . Elevated level of serum LDH and AST indicates tissue damage related to endothelial vascular damage and is the main cause of the occurrence of preeclampsia [21, 22] . Qublan HS showed 92% patients had multi-organ dysfunction in severe preeclamptic women having LDH>800 IU/l. Severely preeclamptic women with LDH >800 IU/l showed significant increase in terms of eclampsia, abruptio placenta, intracranial hemorrhage, HELLP syndrome, acute renal failure, disseminated intravascular coagulation, and pulmonary edema compared with women who had lower levels (p<0.001) [22] . In this study hypertensive mothers with LDH levels > 600IU/l were seen in 77.7% maternal deaths, out of these three mothers (42.8%) had LDH > 800 IU/l. Serum LDH > 600IU/l was also observed in hypertensive mothers having 17.5% preterm deliveries and 46.2% were eclamptic (Table 5 ). Higher levels of serum LDH and AST are very useful markers to identify the occurrence of the complications of preeclampsia in early pregnancy which may reduce the risk of occurrence of disease [7, 23] . Maternal complications were seen in 37% preeclamptic women with abnormal liver function tests (P<0.01) than in preeclamptic women with normal LFT [24] . APTT is probably a practical and cost-effective way to screen for consumptive coagulopathy in preeclampsia [25] . Bad laboratory results and the intensification of clinical signs with multi-organ dysfunction are indications for termination of pregnancy [26] .
IV. Conclusion:
Preeclampsia is a multisystem disorder, characterized by vascular endothelial dysfunction. We found a statistically significant difference between serum uric acid, LDH, AST, ALT, and APTT with maternal death in PIH cases. So higher levels of these parameters can be very useful markers to identify the occurrence of the complications of preeclampsia in early pregnancy and help in the management of the women with preeclampsia.
